Loading...
XHKG
8225
Market cap18mUSD
Dec 05, Last price  
0.15HKD
1D
2.80%
1Q
-14.04%
Jan 2017
-26.13%
IPO
-45.07%
Name

China Health Group Inc

Chart & Performance

D1W1MN
XHKG:8225 chart
P/E
—
P/S
5.02
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.05%
Rev. gr., 5y
-15.99%
Revenues
26m
+23.47%
42,157,00057,052,00038,729,00039,186,00047,308,00037,687,00018,099,00028,688,00014,931,0005,956,00020,497,00020,241,00058,491,00059,606,00063,216,00083,063,00083,601,00013,090,00021,425,00026,454,000
Net income
-15m
L-74.97%
5,644,00015,563,0001,597,000-16,354,0006,276,000-56,928,000-153,796,0003,118,000-31,028,00044,117,000-3,353,0002,127,00030,454,00023,164,00027,792,00060,650,00036,325,000-15,843,000-58,014,000-14,519,000
CFO
10m
+817.40%
-734,000-1,836,000-22,623,000-30,653,0006,231,000-714,0006,716,000-6,617,000-1,779,00011,0003,390,000-6,893,00014,394,0002,858,000-485,00019,114,000-10,277,000-5,156,0001,121,00010,284,000
Dividend
Apr 07, 20040.005 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
URL
http://www.chgi.net
IPO date
Jul 10, 2003
Employees
40
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT